Full Text View
Tabular View
No Study Results Posted
Related Studies
Effects of Nefazodone on Treatment of Female Cocaine Abusers - 3
This study has been completed.
Study NCT00000286   Information provided by National Institute on Drug Abuse (NIDA)
First Received: September 20, 1999   Last Updated: August 16, 2005   History of Changes

September 20, 1999
August 16, 2005
December 1996
 
  • Craving
  • Drug use
  • Depression
  • Life functioning
  • HIV risk behaviors
Same as current
Complete list of historical versions of study NCT00000286 on ClinicalTrials.gov Archive Site
 
 
 
Effects of Nefazodone on Treatment of Female Cocaine Abusers - 3
Effects of Nefazodone on Treatment of Female Cocaine Abusers

The purpose of this study is to determine the effects of nefazedone on cocaine self-administration in depressed and non-depressed female cocaine users.

This study evaluated the effect of nefazodone on reducing cocaine use and craving in both depressed and nondepressed women and if there was a greater effect in depressed women.

Phase II
Interventional
Treatment, Double-Blind, Placebo Control
Cocaine-Related Disorders
Drug: Nefazodone
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
0
December 2001
 

Inclusion Criteria:

Females, ages 18-55, minimum use of 8 days of the last 30, minimum of 8th grade education, current diagnosis of cocaine abuse/dependence

Exclusion Criteria:

Unstable medical illness, dx of MR, OBS, bipolar

Female
18 Years to 55 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00000286
 
NIDA-09259-3, P50-09259-3
National Institute on Drug Abuse (NIDA)
University of Minnesota
Principal Investigator: Dorothy Hatsukami, Ph.D. University of Minnesota
National Institute on Drug Abuse (NIDA)
December 1998

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP